Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: Characterization of tissue-specific ING1 transcripts and a homologue gene

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6197-6204

  Jäger, Dirk ^a,c   Stockert, Elisabeth ^b   Scanlan, Matthew J ^b   Güre, Ali O ^b   Jäger, Elke ^c   Knuth, Alexander ^c   Old, Lloyd J ^b   Chen, Yao Tseng ^a,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c KRANKENHAUS NORDWEST   (Germany)

^d WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MESSENGER RNA; TUMOR ANTIGEN;

ARTICLE; BREAST CANCER; EXON; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA TRANSCRIPTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TESTIS; TRANSCRIPTION INITIATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CLONING, MOLECULAR; DNA-BINDING PROTEINS; FEMALE; GENE LIBRARY; GENES, TUMOR SUPPRESSOR; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; TESTIS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0342879921     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Shimokawara, I., Imamura, M., Yamanaka, N., Ishii, V., and Kikuchi, K. Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T- and B-cell sera. Cancer (Phila.). 49: 1456-1464, 1982.
2. Giorno, R. Mononuclear cells in malignant and benign human breast tissue. Arch. Pathol. Lab. Med., 107: 415-417, 1983.
3. Bhan, A. K., and DesMarais, C. L. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. J. Natl. Cancer Inst., 71: 507-516, 1983.
4. Hurlimann, J., and Saraga, P. Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies. Int. J. Cancer. 35: 753-762, 1985.
5. Gottlinger, H. G., Rieber, P., Gokel, J. M., Lohe, K. J., and Riethmuller, G. Infiltrating mononuclear cells in human breast carcinoma: predominance of T4+ rnonocytic cells in the tumor stroma. Int. J. Cancer. 35: 199-205, 1985.
6. Ben-Ezra, J., and Shcibani, K. Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast. Cancer (Phila.), 59: 2037-2041, 1987.
7. Gaffey, M. J., Frierson, H. F., Jr., Mills, S. E., Boyd, J. C., Zarbo, R. J., Simpson, J. F., Gross, L. K., and Weiss, L. M. Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod. Pathol., 6: 721-728, 1993.
8. Hsu, S. M., Raine, L., and Nayak, R. N. Medullary carcinoma of breast an immunohistochemical study of its lymphoid stroma. Cancer (Phila.), 48: 1368-1376, 1981.
9. Hirschl, S., Black, M. M., and Kwon, C. S. Ultrastructural characteristics of sinus histiocytic reaction in lymph nodes draining various stages of breast cancer. Cancer (Phila.), 38: 807-817, 1976.
10. Black, M. M., Barclay, T. H., and Hankey, B. F. Prognosis in breast cancer utilizing histologic characteristics of the primary tumor. Cancer (Phila.). 36: 2048-2055, 1975.
11. Fisher, E. R., Anderson, S., Redmond, C., and Fisher, B. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer (Phila.), 71: 2507-2514, 1993.
12. Black, M. M., Zachrau, R. E., Shore, B., Moore, D. H., and Leis, H. P., Jr. Prognostically favorable immunogens of human breast cancer tissue: antigenic similarity to murine mammary tumor virus. Cancer (Phila.), 35: 121-128, 1975.
13. Springer, G. F. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J. Mol. Med., 75: 594-602, 1997.
14. Gnjatic, S., Cai, Z., Viguier, M., Chouaib, S., Guillet, J. G., and Choppin, J. Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J. Immunol., 160: 328-333, 1998.
15. Disis, M. L., Calenoff, E., McLaughlin, G., Murphy, A. E., Chen, W., Groner, B., Jeschke, M., Lydon, N., McGlynn, E., Livingston, R. B., Moe, R., and Cheever, M. A. Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res., 54: 16-20, 1994.
16. Disis, M. L., and Cheever, M. A. HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer. Adv. Cancer Res., 71: 343-371, 1997.
17. Oettgen, H. F., Livingston, P. O., and Old, L. J. Immunotherapy by active specific immunization. Clinical applications. In: V. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Biologic Therapy of Cancer, Vol. 1, pp. 682-701. Philadelphia: J. B. Lippincott Company, 1991.
18. Boon, T., and van der Bruggen, P. Human tumor antigens recognized by T lymphocytes. J. Exp. Med., 183: 725-729, 1996.
19. Kawakami, Y., and Rosenberg, S. A. Human tumor antigens recognised by T-cells. Immunol. Res., 16: 313-339, 1997.
20. Sahin, U., Tureci, O., Schmitt, H., Cochlovius, B., Johannes, T., Schmits, R., Stenner, F., Luo, G., Schobert, I., and Pfreundschuh, M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA, 92: 11810-11813, 1995.
21. Sahin, U., Tureci, O., and Pfreundschuh, M. Serological identification of human tumor antigens. Curr. Opin. Immunol., 9: 709-716, 1997.
22. Old, L. J., and Chen, Y. T. New paths in human cancer serology. J. Exp. Med., 187: 1163-1167, 1998.
23. Chen, Y. T., Scanlan, M. J., Sahin, U., Tureci, O., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., and Old, L. J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening Proc. Natl. Acad. Sci. USA, 94: 1914-1918, 1997.
24. Tureci, O., Sahin, U., Schobert, I., Koslowski, M., Scmitt, H., Schild, H. J., Stenner, F., Seitz, G., Rammensee, H. G., and Pfreundschuh, M. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res., 56: 4766-4772, 1996.
25. Garkavtsev, I., Kazarov, A., Gudkov, A., and Riabowol, K. Suppression of the novel growth inhibitor p331NG1 promotes neoplastic transformation. Nat. Genet., 14: 415-420, 1996.
26. Carey, T. E., Lloyd, K. O., Takahashi, T., Travassos, L. R., and Old, L. J. AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization. Proc. Natl. Acad. Sci. USA, 76: 2898-2902, 1979.
27. Van den Eynde, B., Hainaut, P., Herin, M., Knuth, A., Lemoine, C., Weynants, P., van der Bruggen, P., Fauchet, R., and Boon, T. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int. J. Cancer. 44: 634-640, 1989.
28. Frederick, M., Ausubel, R. B., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Current protocols in molecular biology In: V. B. Chanda (ed.), Vol. 1, pp. 4.2.1-4.2.9. New York: John Wiley & Sons, Inc., 1997.
29. Tureci, O., Sahin, U., Zwick, C., Koslowski, M., Seitz, G., and Pfreundschuh, M. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc. Natl. Acad. Sci. USA. 95: 5211-5216, 1998.
30. Gure, A. O., Tureci, O., Sahin, U., Tsang, S., Scanlan, M. J., Jager, E., Knuth, A., Pfreundschuh, M., Old, L. J., and Chen, Y. T. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int. J. Cancer, 72: 965-971. 1997.
31. Chen, Y. T., Stockert, E., Chen, Y., Garin-Chesa, P., Rettig, W. J., van der Bruggen, P., Boon, T., and Old, L. J. Identification of the MAGE-I gene product by monoclonal and polyclonal antibodies. Proc. Natl. Acad. Sci. USA, 91: 1004-1008, 1994.
32. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
33. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J. P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethe, B., Lurquin, C., Brasseur, B., Chomez., P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization, and expression of 12 genes of the MAGE family, Immunogenetics, 40: 360-369, 1994.
34. Stockert, E., Jager, E., Chen, Y. T., Scanlan, M. J., Gout, I., Karbach, J., Arand, M., Knuth, A., and Old, L. J. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens [see comments]. J. Exp. Med., 187: 1349-1354, 1998.
35. Gure, A. O., Altorki, N. K., Stockert, E., Scanlan, M. J., Old, L. J., and Chen, Y. T. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res., 58: 1034-1041, 1998.
36. Scanlan, M. J., Chen, Y. T., Williamson, B., Gure, A. O., Stocken, E., Gordan, J. D., Tureci, O., Sahin, U., Pfreundschuh, M., and Old, L. J. Characterization of human colon cancer antigens recognized by autologous antibodies. Int. J. Cancer, 76: 652-658, 1998.
37. Garkavtsev, I., Grigorian, I. A., Ossovskaya, V. S., Chernov, M. V., Chumakov, P. M., and Gudkov, A. V. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control [see comments). Nature (Lond.), 391: 295-298, 1998.
38. Chen, Y. T., Gure, A. O., Tsang, S., Stockert, E., Jager, E., Knuth, A., and Old, L. J. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. USA. 95: 6919-6923, 1998.
39. Tureci, O., Sahin, U., and Pfreundschuh, M. Serological analysis of human tumor antigens: molecular definition and implications. Mol. Med. Today, 3: 342-349, 1997.
40. Brass, N., Heckel, D., Sahin, U., Pfreundschuh, M., Sybrecht, G. W., and Meese, E. Translation initiation factor eIF-4γ is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum. Mol. Genet., 6: 33-39, 1997.
41. Sahin, U., Tureci, O., Chen, Y. T., Seitz, G., Villena-Heinsen, C., Old, L. J., and Pfreundschuh, M. Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int. J. Cancer. 78: 387-389, 1998.
42. Boel, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J. C., Coulie, P., Boon, T., and van der Bruggen, P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2: 167-175, 1995.
43. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 182: 689-698, 1995.
44. Tureci, O., Chen, Y. T., Sahin, U., Gure, A. O., Zwick, C., Villena, C., Tsang, S., Seitz, G., Old, L. J., and Pfreundschuh, M. Expression of SSX genes in human tumors. Int. J. Cancer, 77: 19-23, 1998.
45. Garkavtsev, I., and Riabowol, K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol. Cell. Biol., 17: 2014-2019, 1997.
46. Helbing, C. C., Veillette, C., Riabowol, K., Johnston, R. N., and Garkavtsev, I. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res., 57: 1255-1258, 1997.
47. Garkavtsev, I., Demetrick, D., and Riabowol, K. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (INGI). Cytogenet. Cell Genet., 76: 176-178, 1997.
48. Kerangueven, F., Noguchi, T., Coulier, F., Allione, F., Wargniez, V., Simony-Lafontaine, J., Longy, M., Jacquemier, J., Sobol, H., Eisinger, F., and Birnbaum, D. Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. Cancer Res., 57: 5469-5474, 1997.
49. Devilee, P., and Cornelisse, C. J. Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta, 1198: 113-130, 1994.
50. Garkavtsev, I., Boland, D., Mai, J., Wilson, H., Veillette, C., and Riabowol, K. Specific monoclonal antibody raised against the p33ING1 tumor suppressor. Hybridoma, 16: 537-540, 1997.